FDA disapproves Novartis’s Biosimilar drug, Roche’s fears alleviated
  Author: Dhananjay Punekar

Roche AG, a Switzerland based healthcare organization, seems to have breathed a sigh of relief with the FDA refusing t...

Read More
Google & Fitbit collaborate to transform the future of digital health
  Author: Dhananjay Punekar

Google Inc. and Fitbit Inc., a renowned U.S. firm across the wearables sector, have apparently declared to join hands ...

Read More
West China Hospital & Oxford University Press launch medical journal
  Author: Saipriya Iyer

The Oxford University Press, the largest university press across the globe, in association with the West China Hospita...

Read More
J&J succeeds in overturning a $151 million hip implant ruling
  Author: Saif Ali Bepari

Johnson & Johnson, the multinational pharmaceutical and biotechnology major, has apparently announced that it has ...

Read More
Eli Lilly-NCCD deal to advance understanding of Type 2 diabetes & CVD
  Author: Dhananjay Punekar

Eli Lilly and Company, the globally renowned pharma titan, has scarcely announced a strategic collaboration with the N...

Read More
douglas-pharma-and-uwa-join-hands-for-developing-new-cancer-therapies
  Author: Dhananjay Punekar

Douglas Pharmaceuticals Limited, a key pharma product manufacturer headquartered in New Zealand, has signed a partners...

Read More
Merck gets approval for its CRISPR genome-editing technology in China
  Author: Dhananjay Punekar

Merck KGaA has declared that the Chinese Patent Office has provided it with the right to use its CRISPR gene-editing t...

Read More
Biotech firm Ayoxxa Biosystems unveils Lunaris Human 12-Plex Th17 Kit
  Author: Saif Ali Bepari

The Germany headquartered biotechnology firm Ayoxxa Biosystems GmbH has apparently announced the expansion of its prod...

Read More
J&J buys Bristol-Myers Squibb’s Factor XIa inhibitor program
  Author: Paroma Bhattacharya

The pharmaceutical giant Johnson & Johnson has reportedly entered into a collaboration with Bristol-Myers Squibb f...

Read More
Amazon abandons its plans to sell & distribute medicines to hospitals
  Author: Dhananjay Punekar

Amazon Business has reportedly decided to drop its plans of selling & distributing pharma items to hospitals. Curren...

Read More
Merck races ahead of Bristol-Myers in lung cancer drug therapy
  Author: Dhananjay Punekar

Pharma major Merck has apparently emerged at the top, surpassing Bristol-Myers Squibb, in the results of the clinical tr...

Read More
Shire strikes deal with Servier to sell its cancer unit for USD 2.4B
  Author: Dhananjay Punekar

Shire Plc, a global specialty biopharma firm headquartered in Ireland, has apparently entered into an agreement with a F...

Read More
Howard county considers Elkridge to setup drug treatment center
  Author: Paroma Bhattacharya

Howard county, a region that made it to the headlines due to its soaring numbers of opioid related fatalities, is expe...

Read More
Accelerating Australia turns leader to transform biomedical expertise
  Author: Dhananjay Punekar

Accelerating Australia, a Biomedical Innovation Group based in Western Australia, has received funds from a consortium...

Read More
FDA permits AI-powered medical device to detect diabetic eye ailment
  Author: Dhananjay Punekar

In what may be touted to be a highly victorious incidence in the medical devices industry, the U.S. FDA has approved t...

Read More
Fight against opioid overdose depicts success in Huntington city
  Author: Dhananjay Punekar

Huntington city seems to have reportedly been very successful in combating the opioid overdose epidemic in the region....

Read More
oDocs creates world-first AI medical platform for auto-diagnosis
  Author: Dhananjay Punekar

Dunedin firm oDocs, based in New Zealand, has apparently developed the world’s first AI-based medical platform f...

Read More
WuXi Biologics & Adagene partner to generate new antibody therapeutics
  Author: Dhananjay Punekar

WuXi Biologics, an open-access biologics technology platform firm offering end-to-end services for exploring, developi...

Read More
Apple to introduce tech compatible healthcare service for employees
  Author: Dhananjay Punekar

Tech magnate Apple has reportedly planned to launch its primary medical care service referred to as AC Wellness. The f...

Read More
Mainstay Medical receives €30 million funding from investors
  Author: Dhananjay Punekar

Mainstay Medical International plc, a firm that manufactures medical implantable device ReActiv8 ®, has raised fun...

Read More
FDA approves wearable device Embrace for seizure detection
  Author: Dhananjay Punekar

Empatica Incorporation, reputed for developing wearable medical sensors based on human data analytics, has reportedly ...

Read More
Nestle pulls out of bid to buy Merck’s consumer health business
  Author: Dhananjay Punekar

Nestle S.A. has reportedly withdrawn from its bid to buy out the consumer health business of Merck KGaA, the renowned ...

Read More
ACLU sues against FDA restrictions imposed on the convenient access to the so-called abortion pill
  Author: Saipriya Iyer

The American Civil Liberties Union (ACLU) has filed a lawsuit against the federal restrictions imposed by the FDA agai...

Read More
Fosun agrees to purchase India’s Gland Pharma for USD 1.1 billion
  Author: Ojaswita Kutepatil

China’s Fosun Group has reportedly settled for a revised offer to acquire 74% of the Indian company Gland Pharma L...

Read More
Bayer receives approval from the FDA to sell its cancer drug Copanlisib in the U.S.
  Author: Sunil Hebbalkar

The renowned German pharmaceutical, chemical, and life sciences company, Bayer has scarcely received regulatory approval...

Read More
Merck to team up with Project Data Sphere for to lay the groundwork for the Global Oncology Big Data Alliance
  Author: Saipriya Iyer

The globally renowned pharma giant and science and technology leader, Merck & Co., Inc., has scarcely declared its d...

Read More
Eli Lilly set to compete with rivals Pfizer and Novartis on breast cancer drug
  Author: Ojaswita Kutepatil

The results of the recent breast cancer drug trial of the leading pharmaceutical company Eli Lilly is set to challenge i...

Read More
Novartis wins a competitive advantage over Roche for its drug cocktail, Tafiliar and Mekinist
  Author: Satarupa De

Novartis, the Swiss drug maker has recently come up with the results of a clinical trial study from a patient pool detec...

Read More
Merck and Inctye jointly carry out clinical trials of the drug combo treatment with favorable outcomes
  Author: Dhananjay Punekar

Merck & Company, a major pharma giant and Incyte Corporation, reputed to be one of the key players in North America ...

Read More
FDA implicates Pfizer as EpiPen backfires, pharma firm ordered to investigate patient claims
  Author: Saipriya Iyer

The Food and Drug Administration has allegedly accused the pharma giant, Pfizer, of disregarding patient claims of EpiPe...

Read More
Merck & Company to acquire Rigontec for over USD 550 million in a bid to expand its product portfolio
  Author: Dhananjay Punekar

Merck & Company, a key player across the pharmaceutical industry, is planning to acquire Rigontec GmbH, a major part...

Read More
Merck group expands its business in global food safety testing industry, sets up a new food safety testing laboratory in the U.S
  Author: Dhananjay Punekar

Merck Group, a rather formidable pharma behemoth, is all set to enter the emerging field of food safety testing through ...

Read More
Jazz Pharmaceuticals signs a deal with Immunogen to develop and commercialize ADCs
  Author: Sunil Hebbalkar

Ireland-based biopharmaceutical company Jazz Pharmaceuticals is planning to team up with ImmunoGen Inc., one of the many...

Read More
AstraZeneca inks a deal with Japanese drug maker Takeda for developing an antibody therapy, Medi1341
  Author: Satarupa De

U.K. based research driven pharmaceutical leader, AstraZeneca has recently struck a commercial deal with the reputed Jap...

Read More
Ethris and AstraZeneca to collaborate on the development of mRNA therapies for respiratory diseases
  Author: Ojaswita Kutepatil

AstraZeneca, a prominent leader in global pharmaceutical market, has recently announced a five-year strategic research c...

Read More
Corning inks agreements with Gerresheimer and Stevanato Group to manufacture its Valor Glass for injectable drugs
  Author: Saipriya Iyer

Having perceptibly inhabited the front page of most news portals since the last few days, the American glass and ceramic...

Read More
Merck’s ex-official appointed as new R&D head for Johnson & Johnson, Pharma giant opens door for further M&As
  Author: Satarupa De

Johnson & Johnson, Inc., one of the most reputed and popular companies operating in global pharmaceutical market, ...

Read More
Probiotics: The mood alleviating elixir to combat depression or an overrated additive with intangible effects.
  Author: Dhananjay Punekar

A new scientific research study has recently stated that consuming a specific type of probiotic is likely to help batt...

Read More
Henry Ford Health System and Wayne State University discuss partnership to amalgamate their physician groups
  Author: Ojaswita Kutepatil

Wayne State University, one of the many premier American research universities, along with its affiliates, has apparen...

Read More
AstraZeneca’s Imfinzi success unlocks sizable opportunities for the company in lung cancer market, Merck to face a tough dominance battle
  Author: Shikha Sinha

AstraZeneca, the renowned pharmaceutical magnate, has set a new benchmark in the cancer immunotherapy space, post the ...

Read More
Merck’s business earnings go up several notches higher, thanks to the colossal sales of Keytruda
  Author: Shikha Sinha

Merck & Co., Inc., the reputed American pharmaceutical giant, has performed exceptionally well in terms of revenue i...

Read More